Drugs.com
An evergreen explainer on diagnosis and treatment options, noting Wegovy and Zepbound can bring about 15% to 21% weight loss with lifestyle changes.
Recap by typeshit. Full story at Drugs.com.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Houman takes on a question he says many men on Ozempic, Wegovy and Mounjaro ask him. The clip pushes a comment-for-guide offer.
Some women are crediting GLP-1 drugs with new chances at pregnancy. KATV cites a WHO figure that one in six people face infertility in their lifetime.
Loading…